Merrimack Pharmaceuticals IncGewinn- und Verlustrechnung
| Preis (2024-05-17) | 52W Hoch | 52W Tief |
| 15.13 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 4 USD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 14.788.400 | 8,25 | 8,65 |
Kennzahl in 1000 USD | TTM 2022-12-31 | 2022-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - | - | - | - |
Herstellungskosten | - | - | - | - | - | - | - | - | - | - |
Bruttoergebnis | - | - | - | - | - | - | - | - | - | - |
▸ Brutto-Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Betriebliche Aufwendungen | - | - | - | - | - | - | - | - | - | - |
Operativer Gewinn/Verlust | - | - | - | - | - | - | - | - | - | - |
▸ Operative Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Zinsen (Netto) | - | - | - | - | - | - | - | - | - | - |
▸ Zinsausgaben | - | - | - | - | - | - | - | - | - | - |
▸ Zinseinnahmen | - | - | - | - | - | - | - | - | - | - |
Andere Ausgaben | - | - | - | - | - | - | - | - | - | - |
Gewinn vor Steuern | - | - | - | - | - | - | - | - | - | - |
Steueraufwand | - | - | - | - | - | - | - | - | - | - |
Minderheitenanteil | - | - | - | - | - | - | - | - | - | - |
Nettogewinn/-verlust | - | - | - | - | - | - | - | - | - | - |
▸ Netto-Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |